Insider sales are too small to warrant a trading response. Monitor for any C-suite selling at larger volumes or a pattern of accelerating sales ahead of earnings. No immediate action needed.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 2 $161.83entry
- T+1 · 6mo ago +5.11%α +5.83% · $170.10
- T+5 · 5mo ago −1.11%α +1.85% · $160.03
- T+20 · 5mo ago +13.63%α +15.45% · $183.89
- T+60 · 3mo ago +38.94%α +38.08% · $224.84
Price Chart
How similar events traded
Executive Summary
Two Illumina insiders, the Chief Legal Officer and VP/Chief Accounting Officer, sold a combined $178K in open-market sales on May 28-29, 2026. The total value is trivial relative to Illumina's $24.7B market cap (0.0007%), and the sales are consistent with routine portfolio diversification or tax planning. No material signal for the stock.
Key Financial Metrics
Key Facts
- Two insiders sold shares: Chief Legal Officer Davies Scott M sold 615 shares at $160 ($98,400) on 2026-05-29
- VP/Chief Accounting Officer Ericksen Scott D sold 500 shares at $160 ($80,000) on 2026-05-29, plus 1,500 shares at $150.10 ($225,150) on 2026-05-28
- Total open-market sales in the cluster: $403,550 (including the May 28 trade from the broader 7-day window)
- Total value is 0.0016% of Illumina's $24.7B market cap, immaterial
- No C-suite (CEO/CFO) participation; both sellers are non-C-suite officers
- Recent 30-day insider activity shows only 3 sells totaling $404K, consistent with routine pattern
Financial Impact
Total insider sales of $404K represent 0.0016% of market cap, negligible economic impact
Risk Factors
- Insider sales could increase ahead of a negative catalyst (e.g., earnings miss, regulatory setback), but current volume is routine
- Illumina faces ongoing antitrust and regulatory scrutiny in the genomics space, though no new developments in this filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ILMN-1780345965695 |
Track record
29 reports on ILMN
3 of 9 bullish or bearish reports moved the stock their way by T+5. Best: +35.34% at T+60 after the May 14, 2026 report. 6 of 10 went positive at some point.
Filters
- Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $207.01 Now $198.00 −4.35% settles Nov 20
- Nov 12, 20264d ago Insider Cluster Bearish 4/10 Entry $207.01 Now $198.00 +4.35% settles Nov 20
- Nov 10, 20266d ago 144 Neutral 4/10 Entry $212.93 Now $198.00 −7.01% settles Nov 18
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $212.93 Now $198.00 −7.01% settles Nov 18
- Nov 3, 202613d ago 144 Neutral 4/10 Entry $226.54 to $212.93 Now $198.00 −12.60% ▼ −6.01% −5.09% vs SPY
- Oct 30, 202617d ago SC 13G/A Neutral 2/10 Entry $235.99 to $213.13 Now $198.00 −16.10% ▼ −9.69% −6.98% vs SPY
- Oct 30, 202618d ago Court Ruling Bullish 5/10 Entry $226.58 to $220.78 Now $198.00 −12.61% ▼ −2.56% −2.64% vs SPY
- Oct 29, 202618d ago 8-K Bullish 6/10 No price data
- Oct 29, 202618d ago Press Release Bullish 6/10 Entry $235.99 to $213.13 Now $198.00 −16.10% ▼ −9.69% −6.98% vs SPY
- Oct 27, 202620d ago SC 13G/A Neutral 3/10 Entry $288.79 to $226.54 Now $198.00 −31.44% ▼ −21.56% −20.84% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers